References
- MendonçaMAOCunhaFQMurtaEFTavares-MurtaBMFailure of neutrophil chemotactic function in breast cancer patients treated with chemotherapyCancer Chemother Pharmacol200657566367016133528
- de OliveiraCBüttenbenderSPradoWEnhanced and selective antiproliferative activity of Methotrexate-Functionalized-Nanocapsules to human breast cancer cells (MCF-7)Nanomaterials (Basel)20188124
- ShapiraALivneyYDBroxtermanHJAssarafYGNanomedicine for targeted cancer therapy: towards the overcoming of drug resistanceDrug Resist Updat201114315016321330184
- BoylePHowellAThe globalisation of breast cancerBreast Cancer Res201012Suppl 4S721172091
- WelschingerRBendallLJTemporal tracking of cell cycle progression using flow cytometry without the need for synchronizationJ Vis Exp2015102e5284026327278
- MusgroveEACaldonCEBarracloughJStoneASutherlandRLCyclin D as a therapeutic target in cancerNat Rev Cancer201111855857221734724
- CasimiroMCVelasco-VelázquezMAguirre-AlvaradoCPestellRGOverview of cyclins D1 function in cancer and the CDK inhibitor landscape: past and presentExpert Opin Investig Drugs2014233295304
- FustéNPFerrezueloFGaríECyclin D1 promotes tumor cell invasion and metastasis by cytoplasmic mechanismsMol Cell Oncol201635e120347127857971
- HowellACuzickJBaumMATAC Trialists’ GroupResults of the ATAC (Arimidex, tamoxifen, alone or in combination) trial after completion of 5 years’ adjuvant treatment for breast cancerLancet20053659453606215639680
- Early Breast Cancer Trialists’ Collaborative Group (EBCTCG)Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trialsLancet200536594721687171715894097
- HwangESClarkeCAGomezSLReply to survival after lumpectomy and mastectomy for early stage invasive breast cancer: the effect of age and hormone receptor statusCancer2013119173254325523824869
- OlsonECombination Therapies in Advanced, Hormone Receptor-Positive Breast CancerJ Adv Pract Oncol201891435430564467
- HusseinMMGaafarRMAbdel-WarithAMEfficacy and toxicity of metronomic chemotherapy in metastatic breast cancer: Egyptian experienceClin Breast Cancer201717861862828625341
- CortinovisDBerettaGPiazzaEAIOM LombardiaChemotherapy-induced anemia and oncologist perception on treatment: results of a web-based surveyTumori2013991455023548999
- LinWTWenYWChienCRGauCSChiangSCHsiaoFYSuboptimal duration of granulocyte colony-stimulating factor use and chemotherapy-induced neutropenia in women diagnosed with breast cancerClin Ther20143691287129425130388
- ArslanMOzdemirLOral intake of ginger for chemotherapy-induced nausea and vomiting among women with breast cancerClin J Oncol Nurs2015195E92E9726414587
- FabricantDSFarnsworthNRThe value of plants used in traditional medicine for drug discoveryEnviron Health Perspect2001109Suppl 1697511250806
- DevassyJGNwachukwuIDJonesPJCurcumin and cancer: barriers to obtaining a health claimNutr Rev201573315516526024538
- RahimiHRNedaeiniaRSepehri ShamlooANikdoustSKazemi OskueeRNovel delivery system for natural products: Nano-curcumin formulationsAvicenna J Phytomed20166438339827516979
- DeRKunduPSwarnakarSAntimicrobial activity of curcumin against Helicobacter pylori isolates from India and during infections in miceAntimicrob Agents Chemother20095341592159719204190
- GuoLXingYPanRCurcumin protects microglia and primary rat cortical neurons against HIV-1 gp120-mediated inflammation and apoptosisPLoS One201388e7056523936448
- LiuCHHuangHYAntimicrobial activity of curcumin-loaded myristic acid microemulsions against Staphylococcus epidermidisChem Pharm Bull (Tokyo)20126091118112422976319
- LüerSTrollerRAebiCAntibacterial and antiinflammatory kinetics of curcumin as a potential antimucositis agent in cancer patientsNutr Cancer201264797598122973975
- MengBLiJCaoHAntioxidant and antiinflammatory activities of curcumin on diabetes mellitus and its complicationsCurr Pharm Des201319112101211323116316
- AdapalaNChanMMLong-term use of an antiinflammatory, curcumin, suppressed type 1 immunity and exacerbated visceral leishmaniasis in a chronic experimental modelLab Invest200888121329133918794851
- RahimiHRMohammadpourAHDastaniMThe effect of nano-curcumin on HbA1c, fasting blood glucose, and lipid profile in diabetic subjects: a randomized clinical trialAvicenna J Phytomed20166556757727761427
- DurgaprasadSPaiCGVasanthkumarAlvresJFNamithaSA pilot study of the antioxidant effect of curcumin in tropical pancreatitisIndian J Med Res2005122431531816394323
- GuptaSCKismaliGAggarwalBBCurcumin, a component of turmeric: from farm to pharmacyBiofactors201339121323339055
- TerlikowskaKWitkowskaATerlikowskiSCurcumin in chemoprevention of breast cancerPostępy Higieny i Medycyny Doświadczalnej20146857157824864107
- KakaralaMBrennerDEKorkayaHTargeting breast stem cells with the cancer preventive compounds curcumin and piperineBreast Cancer Res Treat2010122377778519898931
- FitzmauriceCAllenCBarberRMGlobal Burden of Disease Cancer CollaborationGlobal, regional, and National cancer incidence, mortality, years of life lost, years lived with disability, and Disability-Adjusted life-years for 32 cancer groups, 1990 to 2015: a systematic analysis for the global burden of Disease StudyJAMA Oncol20173452454827918777
- BlumenHFitchKPolkusVComparison of treatment costs for breast cancer, by tumor stage and type of serviceAm Health Drug Benefits201691233227066193
- KimJKDiehlJANuclear cyclin D1: An oncogenic driver in human cancerJ Cell Physiol2009220229229619415697
- ZiasarabiPHesariABagheriMBaazmMGhasemiFEvaluation of cytotoxicity effects of combination Nano-Curcumin and berberine in breast cancer cell lineIran J Toxicol20181244750
- LiuJLPanYYChenOCurcumin inhibits MCF-7 cells by modulating the NF-κB signaling pathwayOncol Lett20171455581558429142607
- TodaSMiyaseTArichiHTanizawaHTakinoYNatural antioxidants. III. antioxidative components isolated from rhizome of Curcuma longa LChem Pharm Bull1985334172517284042250
- FuMWangCLiZSakamakiTPestellRGMinireview: cyclin D1: normal and abnormal functionsEndocrinology2004145125439544715331580
- KimJHGuptaSCParkBYadavVRAggarwalBBTurmeric (Curcuma longa) inhibits inflammatory nuclear factor (NF)-κB and NF-κB-regulated gene products and induces death receptors leading to suppressed proliferation, induced chemosensitization, and suppressed osteoclastogenesisMol Nutr Food Res201256345446522147524
- LvZDLiuXPZhaoWJCurcumin induces apoptosis in breast cancer cells and inhibits tumor growth in vitro and in vivoInt J Clin Exp Pathol2014762818282425031701
- ChoudhuriTPalSAgwarwalMLDasTSaGCurcumin induces apoptosis in human breast cancer cells through p53-dependent Bax inductionFEBS Lett20025121–333434011852106
- CataniaABarrajón-CatalánENicolosiSCicirataFMicolVImmunoliposome encapsulation increases cytotoxic activity and selectivity of curcumin and resveratrol against HER2 overexpressing human breast cancer cellsBreast Cancer Res Treat20131411556523959397
- HajigholamiSVeisi MalekshahiZBodaghabadiNNajafiFShirzadHSadeghizadehMNano packaged tamoxifen and curcumin; effective formulation against sensitive and resistant MCF-7 cellsIran J Pharm Res2018171110
- HosseiniSChamaniJRahimiHAzmoodehNGhasemiFAbadiPHAn in vitro study on curcumin delivery by nano-micelles for esophageal squamous cell carcinoma (KYSE-30)Rep Biochem Mol Biol20186213714329765996